Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms- |
Target |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Cardiovascular Diseases | Discovery | - | 12 Dec 2024 | |
| Cardiovascular Diseases | Discovery | - | 12 Dec 2024 | |
| Cardiovascular Diseases | Discovery | - | 12 Dec 2024 | |
| Cardiovascular Diseases | Discovery | - | 12 Dec 2024 | |
| Digestive System Disorders | Discovery | - | 12 Dec 2024 | |
| Digestive System Disorders | Discovery | - | 12 Dec 2024 | |
| Digestive System Disorders | Discovery | - | 12 Dec 2024 | |
| Digestive System Disorders | Discovery | - | 12 Dec 2024 | |
| Immune System Diseases | Discovery | - | 12 Dec 2024 | |
| Immune System Diseases | Discovery | - | 12 Dec 2024 |





